Retrons adapted from E. coli enable genome editing in 15 diverse bacterial species, expanding recombineering tools across major microbial phyla.

Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox– Additional presentations ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

The ability to precisely edit the genomes of bacteria has long been a goal of microbiologists. Such technology would enable ...

This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death globally, with incidence continuing to rise in many regions. Despite advances in ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Artificial intelligence is accelerating advances across genetics, from precision genome editing to complete crop genome mapping and personalized disease risk prediction. Recent achievements include ...

A major collaboration involving nine labs, led by scientists at Gladstone Institutes, has transferred a particularly useful ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

Waking up this morning to news of the much-deserved Nobel Prize win for Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing" confirms the importance of ...